Cboe posts record revenue momentum and tighter cost guidance: Q2 surge meets FY strength#
Cboe Global Markets ([CBOE]) recorded record total net revenue of $587.3 million in Q2 2025, a +14.0% year-over-year increase that prompted management to raise full-year organic net revenue guidance to the high single digits and narrow adjusted operating expense guidance. According to press coverage of the quarter, the upside was driven by derivatives activity and growing demand for Data Vantage feeds and analytics, with international markets contributing materially to the top-line lift Cboe Q2 Revenue Hits Record High - Nasdaq and subsequent coverage Cboe Global Markets Beats Estimates With Record Q2 Revenue - Investing.com. This operational momentum sits alongside FY2024 financials that show improving free cash flow and sustained capital returns, but also reveal mixed margin trends at the gross-profit level that require closer scrutiny.
Professional Market Analysis Platform
Make informed decisions with institutional-grade data. Track what Congress, whales, and top investors are buying.
Financial performance snapshot and independent calculations (FY2021–FY2024)#
A review of the audited FY figures (filed Feb 21, 2025) shows Cboe delivered revenue of $4.09 billion in FY2024, up from $3.77 billion in FY2023 — an independently calculated increase of +8.49% YoY. Net income for FY2024 was $764.9 million, virtually flat versus FY2023 (+0.46% YoY). Free cash flow improved to $1.04 billion in FY2024, producing a free-cash-flow margin of +25.43% (free cash flow / revenue). These outcomes underpin discretionary capital returns and provide investment flexibility for Data Vantage and international expansion.
More company-news-CBOE Posts
Cboe Global Markets: Q2 Revenue Beat, Mix Shift, and Balance-Sheet Optionality
Cboe posted record Q2 net revenue of **$587.3M** (+14.00%) and GAAP EPS of **$2.23** (+68.00%), while strengthening cash and cutting net debt — a story of mix-driven margin leverage.
Cboe Global Markets — Q2 Revenue & Derivatives/Data Strategy
Data-driven update: Cboe reports record Q2 revenue, raises organic growth target and reallocates capital toward derivatives and Data Vantage monetization.
Cboe Global Markets Q2 2025 Analysis: Record Revenue and Strategic ETF Launch
Cboe Global Markets reports record Q2 2025 revenue driven by options, international growth, and new ETF launch, highlighting strategic diversification and margin expansion.
Key FY dynamics are visible when comparing line items across the most recent four fiscal years. The tables below summarize the principal income-statement and cash/balance-sheet metrics used for the analysis, with calculations performed from the company’s FY filings (filed 2025-02-21) and the 2025 quarter commentary noted above.
Income statement summary (selected metrics)#
Year | Revenue | Gross Profit | Operating Income | Net Income | Gross Margin | Operating Margin | Net Margin |
---|---|---|---|---|---|---|---|
2024 | $4,090.0M | $1,610.0M | $1,100.0M | $764.9M | 39.32% | 26.92%* | 18.71% |
2023 | $3,770.0M | $1,920.0M | $1,060.0M | $761.4M | 50.83% | 28.11%* | 20.20% |
2022 | $3,960.0M | $1,740.0M | $970.1M | $235.0M | 44.00% | 24.51% | 5.94% |
2021 | $3,490.0M | $1,190.0M | $805.9M | $529.0M | 33.98% | 23.09% | 15.15% |
*Operating margin figures recalculated as Operating Income / Revenue; FY2024 recalculation = 1,100 / 4,090 = 26.92% (rounded). Gross margin and net margin numbers reflect company disclosures in FY filings (filed 2025-02-21).
The headline observation from those numbers is mixed: while revenue and operating income expanded in FY2024 (+8.49% and +3.77% YoY respectively), gross profit declined materially versus FY2023 (-16.15% in absolute dollars) and gross margin contracted from 50.83% to 39.32%. The contraction is driven by higher cost of revenue in 2024; operating leverage limited the dilution at the operating-income line, but the gross-margin move warrants scrutiny because it affects the durable profitability profile of data and execution businesses.
Balance sheet and cash-flow summary (selected metrics)#
Year | Cash & Cash Equivalents | Total Current Assets | Total Assets | Total Debt | Net Debt (total debt - cash) | Free Cash Flow | Dividends Paid | Share Repurchases |
---|---|---|---|---|---|---|---|---|
2024 | $920.3M | $2,480.0M | $7,790.0M | $1,600.0M | $679.7M | $1,040.0M | $249.4M | $204.8M |
2023 | $543.2M | $1,980.0M | $7,490.0M | $1,610.0M | $1,066.8M | $1,030.0M | $223.5M | $83.9M |
2022 | $432.7M | $1,560.0M | $7,000.0M | $1,870.0M | $1,437.3M | $591.3M | $209.4M | $100.9M |
2021 | $341.9M | $1,530.0M | $6,810.0M | $1,430.0M | $1,088.1M | $545.8M | $193.3M | $81.3M |
From a liquidity and capital-allocation perspective, net debt fell to $679.7 million at year-end 2024, down substantially from $1.07 billion at the end of 2023 — an improvement driven by higher cash balances and disciplined free cash flow generation. Free cash flow of $1.04 billion in FY2024 funded $249.4 million of dividends and $204.8 million of share repurchases, for total shareholder distributions of $454.2 million in the year.
Recalculations and notable metric divergences#
Several commonly quoted ratios in vendor-supplied TTM summaries differ from the FY-end ratios when computed directly from the FY2024 filings. Two illustrative examples are net-debt/EBITDA and EV/EBITDA.
Using FY2024 figures, EBITDA = $1.27 billion and net debt = $679.7 million. The FY2024 net-debt/EBITDA calculation yields 0.54x (679.7 / 1,270 = 0.535), materially higher than the dataset's TTM net-debt/EBITDA of 0.21x. Similarly, an enterprise-value estimate built from market capitalization ($25.97B as quoted) plus net debt gives EV ≈ $26.65 billion, producing an EV/EBITDA of ≈ 20.99x (26.65 / 1.27), versus the TTM EV/EBITDA of 17.95x included in vendor metrics.
These divergences reflect the difference between trailing-12-month (TTM) smoothing, intra-year cash swings, and market-cap moves that happen after fiscal-year close. Where vendor TTM metrics are calculated from a different set of rolling periods or include mid-quarter prices and TTM EBITDA inputs, they will not match simple FY-end arithmetic. For transparency, the analysis below uses FY2024 audited figures for structural commentary and cites TTM vendor metrics when discussing market multiples or consensus-based ratios.
Drivers beneath the headline: Data Vantage, derivatives, and geography#
The company’s public commentary and Q2 results indicate the business is moving along three coordinated vectors: (1) derivatives-led transaction revenue, (2) Data Vantage subscription and market-data revenue, and (3) geographic diversification — notably stronger European performance.
Operationally, Q2 2025 brought double-digit growth in derivatives and Data Vantage, with derivatives net revenue up +17% YoY and Data Vantage up +11% YoY according to management commentary cited by Nasdaq and Investing.com. The valuation of these revenue streams differs: data and access products are higher-margin, recurring and sticky, while derivatives revenue is volume-dependent and more cyclical. The shift toward higher shares of international and data revenue helps explain improved adjusted operating margins in the quarter and the decision to lift organic revenue guidance.
However, the FY2024 gross-profit decline compared with FY2023 indicates that some cost categories tied to revenue (cost of revenue) increased meaningfully in the year. This could be a function of product-mix shifts, investments in global feed infrastructure, or timing differences in reimbursables and pass-through costs. Management’s narrowed opex guidance and the announced wind-down of the Japanese equities business (expected to yield $10–$12 million in annual savings but a one-time pretax Q3 2025 charge of roughly $5 million) signal ongoing portfolio optimization.
Capital allocation: dividends, buybacks and balance-sheet posture#
Cboe maintained a steady dividend cadence through FY2024 and into 2025 quarterly payments (quarterly dividend $0.63). Using the FY2024 figures, the cash dividend paid ($249.4M) represents ~32.6% of FY2024 net income (249.4 / 764.9), while total return including repurchases ($454.2M) equates to ~59.4% of net income. Management has prioritized a balanced approach — returning cash to shareholders while preserving the ability to invest in Data Vantage and selective M&A.
Balance-sheet flexibility improved in FY2024: net debt fell to $679.7M, and the company finished the year with $920.3M in cash. Debt levels remain modest relative to earnings and cash generation: using FY2024 EBITDA of $1.27B, total debt to EBITDA is ~= 1.26x (1.60 / 1.27), and net-debt/EBITDA is ~0.54x. Those measures give the company room for disciplined inorganic activity if management chooses, while supporting ongoing repurchases and dividends.
Margin outlook and quality of earnings#
Q2 2025 adjusted operating margin expanded due to revenue mix and operating leverage, but the FY2024 gross-margin contraction is a caution signal. The company’s margin story hinges on the continued scaling of Data Vantage and the ability to hold down revenue-linked costs. Free cash flow conversion is strong — $1.04B of free cash flow on $4.09B of revenue — and cash generation validates capital returns, but investors should watch whether gross margins stabilize as Data Vantage grows and whether cost-of-revenue items that depressed FY2024 gross profit are one-offs or structural.
Quality-of-earnings indicators are positive on cash generation: net cash provided by operating activities was $1.1B in FY2024, roughly in line with reported net income ($764.9M) after adding back non-cash depreciation and amortization (FY2024 D&A = $133M) and working-capital moves. This indicates earnings are not primarily the product of accounting adjustments and that operating cash generation has strengthened.
Competitive and strategic positioning#
Cboe’s core competitive advantages are scale in options derivatives, a growing global distribution of proprietary market data, and technology for market access. The company remains a meaningful player in listed options, although market-share metrics reported in Q2 indicate some share pressure in North America even as Europe and APAC show gains. The strategic priority is clear: sustain derivatives market leadership while accelerating Data Vantage and international expansion to diversify revenue and smooth cyclicality.
Leadership moves — including the appointment of an Executive Vice President to lead enterprise strategy and corporate development effective September 2, 2025 — signal that management is preparing for disciplined inorganic moves to complement organic data growth. The company has been explicit about pruning lower-return operations (e.g., Japan exit) and reallocating capital toward higher-margin products.
Key takeaways#
Cboe finished FY2024 with strong cash generation (free cash flow $1.04B) and a healthier balance sheet (net debt down to $679.7M). The company rode Q2 2025 momentum — record net revenue $587.3M, +14% YoY — to raise guidance and tighten expense expectations. Those developments reinforce the structural thesis that Data Vantage and international expansion can produce recurring, higher-margin revenue to complement derivatives-led transaction fees.
At the same time, FY2024 shows a notable gross-margin contraction, from 50.83% in 2023 to 39.32% in 2024, which requires monitoring to determine whether it reflects short-term cost items, investments to enable future growth, or a secular mix shift that will alter long-run profitability. Vendor TTM multiples and ratios differ from straight FY-end arithmetic; readers should expect some dispersion between FY-based and TTM-based metrics depending on calculation methodologies.
What this means for investors#
Cboe’s near-term financial posture has three practical implications. First, strong free-cash-flow generation provides the company flexibility to fund Data Vantage investments, maintain dividends, and execute measured buybacks without notably levered financing. Second, the Q2 2025 revenue beat and revised guidance indicate management can still drive top-line upside from derivatives and data; sustaining that trajectory is critical to margin expansion. Third, the FY2024 gross-margin decline is the principal risk to a clean margin story — investors should watch upcoming quarters for either stabilization or further margin pressure tied to cost-of-revenue items.
From a capital-allocation lens, the improved net-debt position combined with consistent buybacks and dividends demonstrates balance-sheet discipline. The planned Japan exit (immaterial to 2025 revenue, but producing $10–$12M of annual savings and a one-time pretax charge) is an example of pruning low-return operations to sharpen focus on higher-return global data and derivatives franchises.
Risks and catalysts to watch#
Near-term catalysts include continued derivatives ADV growth, further Data Vantage subscription momentum (especially outside the U.S.), and any announced M&A that enhances data or international scale. Key risks are softer derivatives volumes, persistent cost-of-revenue pressure that prevents gross-margin recovery, and execution challenges in integrating or scaling international data operations.
Conclusion#
Cboe entered 2025 with tangible operational momentum: record quarterly revenue in Q2, improved cash balances, and a tightened expense outlook. The financials show solid cash-generation capacity and prudent capital returns, but the FY2024 gross-margin contraction contrasts with quarter-to-quarter margin improvement and must be watched for persistence. The company’s strategic playbook — protect and extend derivatives leadership while accelerating Data Vantage and international expansion — is coherent and funded by strong FCF. The critical question for stakeholders is whether the company can both scale recurring data revenues and arrest the gross-margin volatility that emerged in FY2024.
Sources: FY2024 financial statements (filed 2025-02-21); Q2 2025 quarter coverage and commentary Cboe Q2 Revenue Hits Record High - Nasdaq; Cboe Global Markets Beats Estimates With Record Q2 Revenue - Investing.com.